Cargando…
Liposomal glutathione as a promising candidate for immunological rheumatoid arthritis therapy
Nano-medicine can passively accumulate in chronic inflammatory tissues via the enhanced permeability and retention phenomenon, or by being conjugated with a ligand that can bind to receptors over expressed by cells inside chronic inflammatory tissues, contributing to reduced systemic side-effects an...
Autor principal: | Kadry, Mai O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661417/ https://www.ncbi.nlm.nih.gov/pubmed/31384691 http://dx.doi.org/10.1016/j.heliyon.2019.e02162 |
Ejemplares similares
-
Liposomal Nanosystems in Rheumatoid Arthritis
por: Ferreira-Silva, Margarida, et al.
Publicado: (2021) -
Increased Encapsulation Efficiency of Methotrexate in Liposomes for Rheumatoid Arthritis Therapy
por: Guimarães, Diana, et al.
Publicado: (2020) -
Application of Liposomes in Treatment of Rheumatoid Arthritis: Quo Vadis
por: Kapoor, Bhupinder, et al.
Publicado: (2014) -
Dendritic cells and the promise of antigen-specific therapy in rheumatoid arthritis
por: Thomas, Ranjeny
Publicado: (2013) -
Effect of climatic environment on immunological features of rheumatoid arthritis
por: Kondo, Yuya, et al.
Publicado: (2023)